India, 24 July 2025: Abhay HealthTech Pvt. Ltd. continues to lead India’s shift toward consumer-controlled, preventive healthcare with an expanded portfolio of rapid diagnostics, hygiene essentials, wellness products, and telehealth solutions.
This aligns with major market trends. India’s OTC drug segment is now valued at approximately USD 6.7 billion in 2025, with a projected CAGR of 5.4% through 2033 (Data Insights Market).
Likewise, the home healthcare market reached USD 5.7 billion in 2024 and is set to grow to over USD 11.6 billion by 2030, at nearly 13% CAGR (Grand View Research).
Why the momentum?
- Growing need for at-home testing: India’s rapid test kit market was worth approx. USD 403 million in 2024 and is expected to reach USD 605 million by 2030 (CAGR 6.8%) (GlobeNewswire).
- Surging self-care: OTC pain relief alone has ballooned to ₹16,000 crore (~ USD 2 billion) by mid-2025—highlighting growing consumer preference for convenience and immediate relief (ijpsjournal).
- Medical devices on the rise: With hypertension rising, BP monitor penetration remains low at ~6%—but is doubling and expanding dramatically as consumers adopt home care devices (Reuters).
Better Health Begins at Home
With features like easy use, lab-accurate results in minutes, and versatility across home, clinic, and remote settings, Abhay’s Assure and ActFast lines are designed to meet widespread demand.
Innovation & Quality You Can Trust
- ISO-certified manufacturing and adherence to stringent statutory standards
- Clinically validated accuracy (99%+) across rapid diagnostics
- Leading the charge in OTC wellness categories—from hygiene and skincare to baby and women’s health
- Supported by an expert advisory board with former leaders from Reckitt, J&J, and Columbia Asia
Apurv Modi, Managing Director, reiterates: “Innovation isn’t just about something new; it’s about something that truly matters. We bridge the gap between traditional care and modern convenience so people can take control of their health at home.”
Why This Matters Now
As India invests only ~2.1% of GDP in healthcare, and with a growing middle class seeking affordable and proactive solutions, Abhay Health is meeting a critical need.
Its health-tech-enabled ecosystem delivers rapid diagnostics, preventive products, hospital consulting, and tele-health solutions all tailored to Indian households, clinics, and communities.
About Abhay Health
Abhay Health is a diversified, purpose-driven healthcare company delivering accessible, research-backed, and cost-effective solutions spanning diagnostics, wellness, hygiene, and health-tech. Backed by leadership expertise and strategic investors like Vindu Singh, the company is setting new benchmarks in consumer healthcare across India.
Disclaimer:- This story has not been edited by SugerMint staff and provided by the agency. SugerMint will not be responsible in any way for the content of this story.
| Are you an
Entrepreneur or Startup? Do you have a Success Story to Share? SugerMint would like to share your success story. We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
|
Read more Press Releases at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn